• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of recurrent hepatocellular carcinoma after resection.

作者信息

Tan Hwee Leong, Goh Brian K P

机构信息

Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.

Duke-NUS Medical School Singapore, Singapore, Singapore.

出版信息

Hepatobiliary Surg Nutr. 2020 Dec;9(6):780-783. doi: 10.21037/hbsn.2020.03.07.

DOI:10.21037/hbsn.2020.03.07
PMID:33299834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7720055/
Abstract
摘要

相似文献

1
Management of recurrent hepatocellular carcinoma after resection.肝切除术后复发性肝细胞癌的管理
Hepatobiliary Surg Nutr. 2020 Dec;9(6):780-783. doi: 10.21037/hbsn.2020.03.07.
2
Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.射频消融与再次切除治疗初始根治性切除后复发的≤5cm 肝细胞癌。
Eur Radiol. 2020 Nov;30(11):6357-6368. doi: 10.1007/s00330-020-06990-8. Epub 2020 Jun 11.
3
Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus.肝切除术后复发和转移性肝细胞癌的多学科管理：一项国际专家共识
Hepatobiliary Surg Nutr. 2018 Oct;7(5):353-371. doi: 10.21037/hbsn.2018.08.01.
4
Liver resection for recurrent hepatocellular carcinoma to improve survivability: a proposal of indication criteria.肝切除术治疗复发性肝细胞癌以提高生存率：适应证标准的建议。
Surgery. 2018 Jun;163(6):1250-1256. doi: 10.1016/j.surg.2017.12.022. Epub 2018 Feb 14.
5
Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation.高分化肝细胞癌肝切除术后的复发模式及危险因素：特别提及术后多中心癌变
Hepatogastroenterology. 1999 Nov-Dec;46(30):3212-5.
6
Successful en bloc resection of recurrent hepatocellular carcinoma directly invading the abdominal wall: a case report.成功整块切除直接侵犯腹壁的复发性肝细胞癌：一例报告
J Med Case Rep. 2015 Jan 22;9:19. doi: 10.1186/1752-1947-9-19.
7
Resection of the caudate lobe of the liver for primary and recurrent hepatocellular carcinomas.肝尾状叶切除术治疗原发性和复发性肝细胞癌
J Am Coll Surg. 1997 Jan;184(1):1-8.
8
Cost-effectiveness of adjuvant interferon therapy after surgical resection of Hepatitis C-related hepatocellular carcinoma.丙型肝炎相关肝细胞癌手术切除后辅助干扰素治疗的成本效益
Liver. 2002 Dec;22(6):479-85. doi: 10.1034/j.1600-0676.2002.01736.x.
9
Surgical resection of recurrent extrahepatic hepatocellular carcinoma with tumor thrombus extending into the right atrium under cardiopulmonary bypass: a case report and review of the literature.体外循环下手术切除复发性肝外肝细胞癌伴肿瘤血栓延伸至右心房：1例病例报告并文献复习
Surg Case Rep. 2016 Dec;2(1):110. doi: 10.1186/s40792-016-0241-7. Epub 2016 Oct 11.
10
Favorable quality of life after repeat hepatic resection for recurrent hepatocellular carcinoma.复发性肝细胞癌再次肝切除术后良好的生活质量。
Hepatogastroenterology. 2001 Mar-Apr;48(38):506-10.

引用本文的文献

1
TREM1 is essential for maintaining stemness of liver cancer stem-like cells in hepatocellular carcinoma.触发受体表达于髓系细胞-1（TREM1）对于维持肝细胞癌中肝癌干细胞样细胞的干性至关重要。
Front Immunol. 2025 Jul 3;16:1618342. doi: 10.3389/fimmu.2025.1618342. eCollection 2025.
2
Efficacy and safety of transcatheter arterial embolization combined with ablation and regorafenib for unresectable hepatocellular carcinoma patients failing first-line treatment: a real-world study.经动脉导管栓塞联合消融及瑞戈非尼治疗一线治疗失败的不可切除肝细胞癌患者的疗效与安全性：一项真实世界研究
J Gastrointest Oncol. 2025 Jun 30;16(3):1050-1059. doi: 10.21037/jgo-2025-337. Epub 2025 Jun 27.
3
Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma.经导管动脉化疗栓塞术（TACE）联合靶向免疫治疗中晚期肝细胞癌的安全性和有效性分析。
Med Oncol. 2023 Jul 27;40(9):251. doi: 10.1007/s12032-023-02082-x.
4
Microwave Ablation of Recurrent Hepatocellular Carcinoma after Curative Surgical Resection.根治性手术切除后复发性肝细胞癌的微波消融
J Clin Med. 2023 Mar 29;12(7):2560. doi: 10.3390/jcm12072560.
5
Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study.经导管动脉化疗栓塞术（TACE）联合仑伐替尼和 PD-1 抑制剂治疗不可切除复发性肝细胞癌（HCC）的疗效和安全性：一项多中心回顾性研究。
Cancer Med. 2023 May;12(10):11513-11524. doi: 10.1002/cam4.5880. Epub 2023 Mar 31.

本文引用的文献

1
Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.经动脉化疗栓塞联合射频消融与单纯经动脉化疗栓塞治疗手术切除后复发性肝细胞癌的长期疗效
Dig Dis Sci. 2020 Apr;65(4):1266-1275. doi: 10.1007/s10620-019-05733-0. Epub 2019 Jul 17.
2
Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma.术前预测指标包括炎症指标在预测复发性肝细胞癌再次切除后早期复发中的作用。
World J Surg. 2019 Oct;43(10):2587-2594. doi: 10.1007/s00268-019-05051-6.
3
Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: A comparison with primary liver transplant.复发性肝细胞癌挽救性肝移植的结果：与初次肝移植的比较。
Ann Hepatobiliary Pancreat Surg. 2019 Feb;23(1):1-7. doi: 10.14701/ahbps.2019.23.1.1. Epub 2019 Feb 28.
4
Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy.复发性肝细胞癌治疗策略的系统评价：挽救性肝移植还是根治性局部治疗。
Medicine (Baltimore). 2019 Feb;98(8):e14498. doi: 10.1097/MD.0000000000014498.
5
Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus.肝切除术后复发和转移性肝细胞癌的多学科管理：一项国际专家共识
Hepatobiliary Surg Nutr. 2018 Oct;7(5):353-371. doi: 10.21037/hbsn.2018.08.01.
6
Perioperative Outcomes of Laparoscopic Repeat Liver Resection for Recurrent HCC: Comparison with Open Repeat Liver Resection for Recurrent HCC and Laparoscopic Resection for Primary HCC.复发性肝癌腹腔镜再次肝切除的围手术期结果：与复发性肝癌开腹再次肝切除及原发性肝癌腹腔镜切除的比较
World J Surg. 2019 Mar;43(3):878-885. doi: 10.1007/s00268-018-4828-y.
7
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理：美国肝病研究协会2018年实践指南
Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.
8
Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis.挽救性肝移植或再次肝切除术治疗复发性肝细胞癌：意向治疗分析。
Liver Transpl. 2017 Dec;23(12):1553-1563. doi: 10.1002/lt.24952.
9
A systematic review and meta-analysis comparing the prognosis of multicentric occurrence and vs. intrahepatic metastasis in patients with recurrent hepatocellular carcinoma after hepatectomy.一项比较肝切除术后复发性肝细胞癌患者多中心发生与肝内转移预后的系统评价和荟萃分析。
HPB (Oxford). 2017 Oct;19(10):835-842. doi: 10.1016/j.hpb.2017.06.002. Epub 2017 Jul 19.
10
Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial.腹腔镜与开腹结直肠肝转移灶切除术的比较：OSLO-COMET 随机对照试验。
Ann Surg. 2018 Feb;267(2):199-207. doi: 10.1097/SLA.0000000000002353.